122 related articles for article (PubMed ID: 38394535)
1. Prognostic factors and clinical survival outcome in patients with primary mediastinal diffuse large B-cell lymphoma in rituximab era: A population-based study.
Hang H; Zhou H; Ma L
Medicine (Baltimore); 2024 Feb; 103(8):e37238. PubMed ID: 38394535
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological features for primary lymphoma of the female genital tract patients and development of a nomogram to predict survival.
Peng F; Li J; Mu S; Qin Y; Ma J; Ai L; Hu Y
Ann Med; 2022 Dec; 54(1):962-976. PubMed ID: 35416104
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Prognostic Factors and Survival Outcome in Patients With Primary Hepatic Lymphoma.
Zhang SL; Chen C; Rao QW; Guo Z; Wang X; Wang ZM; Wang LS
Front Oncol; 2020; 10():750. PubMed ID: 32477954
[No Abstract] [Full Text] [Related]
4. Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival.
Peng F; Li J; Mu S; Cai L; Fan F; Qin Y; Ai L; Hu Y
Breast; 2021 Jun; 57():49-61. PubMed ID: 33774459
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategies and survival outcomes of primary mediastinal large B-cell lymphoma.
Quan L; He Z; Zuo X; Cao L; Wang Y; Dai H; Wu W; Shi X; Liu H
Hematology; 2023 Dec; 28(1):2217396. PubMed ID: 37260259
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and survival outcome of primary pulmonary acinar cell carcinoma.
Meng FJ; Sun ZN; Wang ZN; Ma HM; Zhang WC; Gao ZY; Ji LL; Feng FK; Yang B; Wang CY; Chen ZY; Zhang N; Wang GS
Thorac Cancer; 2021 Sep; 12(18):2439-2448. PubMed ID: 34337871
[TBL] [Abstract][Full Text] [Related]
7. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
[TBL] [Abstract][Full Text] [Related]
8. Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.
Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):126-132. PubMed ID: 26547384
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
10. Investigation of epidemiological characteristics and development of a nomogram to predict survival in primary ocular adnexal lymphoma.
Peng F; Su W; Zhang A; Huo B; Song T; Wei Z; Geng Z; Wang L
Clin Exp Ophthalmol; 2022 Aug; 50(6):615-631. PubMed ID: 35656846
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study.
Tang D; Chen Y; Shi Y; Tao H; Tao S; Zhang Q; Ding B; He Z; Yu L; Wang C
Front Oncol; 2022; 12():817043. PubMed ID: 35223498
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic model for patients with colon adenocarcinoma.
Yin C; Wang W; Cao W; Chen Y; Sun X; He K
Front Endocrinol (Lausanne); 2023; 14():1133554. PubMed ID: 36923226
[TBL] [Abstract][Full Text] [Related]
13. Role of radiation therapy in primary mediastinal large B-cell lymphoma in rituximab era: A US population-based analysis.
Giri S; Bhatt VR; Pathak R; Bociek RG; Vose JM; Armitage JO
Am J Hematol; 2015 Nov; 90(11):1052-4. PubMed ID: 26270899
[TBL] [Abstract][Full Text] [Related]
14. Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis.
Liu PP; Wang KF; Jin JT; Bi XW; Sun P; Wang Y; Yang H; Li ZM; Jiang WQ; Xia Y
Cancer Med; 2018 May; 7(5):1845-1851. PubMed ID: 29624913
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology and prognosis of patients with primary gastric T-cell lymphoma in the SEER program.
Zhang M; Xiao F; Lin M; Chen M; Hou J; Huang H
Cancer Med; 2023 Jan; 12(1):84-98. PubMed ID: 35698430
[TBL] [Abstract][Full Text] [Related]
16. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
Xiao M; Lin J; Xiao T; Lin Y; Ye Y
Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
Varelas AN; Ganti A; Eggerstedt M; Tajudeen BA
Laryngoscope; 2019 Dec; 129(12):2675-2680. PubMed ID: 30801751
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and Clinical Significance of Prognostic Nomogram Model for Diffuse Large B-Cell Lymphoma Based on Immunohistochemistry Markers and International Prognostic Index Scores].
Xu YW; Zhou YL; Kong FC; Chen ZW; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):753-761. PubMed ID: 37356936
[TBL] [Abstract][Full Text] [Related]
19. A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Cai J; Tian X; Ma S; Zhong L; Li W; Wang L; Guo L; Li Z; Wu Y; Zhong G; Huang H; Xia Z; Xia Y; Liu P; Su N; Fang Y; Zhang Y; Cai Q
Br J Cancer; 2021 Aug; 125(3):402-412. PubMed ID: 34012033
[TBL] [Abstract][Full Text] [Related]
20. The novel prognostic nomograms for predicting cancer-specific survival and overall survival in mixed medullary and follicular cell carcinoma: A SEER-based study.
Li Y; Guo T; Gao X; Liu J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16337-16354. PubMed ID: 37704803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
